After experimental stroke, EphA4 phosphorylation levels at one of its tyrosine residues (Tyr602) remained stable during the acute (24 h), subacute (day 7) and chronic phase (day 21) (Fig. 3D and E). Here, EPHA4 is linked to stroke disorder.